Replimune
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Replimune and other ETFs, options, and stocks.About REPL
Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer.
REPL Key Statistics
Stock Snapshot
Replimune(REPL) stock is priced at $9.44, giving the company a market capitalization of 781.96M. It carries a P/E multiple of -2.64.
On 2026-06-07, Replimune(REPL) stock traded between a low of $9.39 and a high of $10.46. Shares are currently priced at $9.44, which is +0.5% above the low and -9.8% below the high.
Replimune(REPL) shares are trading with a volume of 4.61M, against a daily average of 9.99M.
During the past year, Replimune(REPL) stock moved between $1.50 at its lowest and $13.24 at its peak.
During the past year, Replimune(REPL) stock moved between $1.50 at its lowest and $13.24 at its peak.
REPL News
REPL Stock Catalyst: RP2 Data Presentation At ASCO It enrolled 85 heavily pretreated patients with advanced solid tumors. On Sunday, the company said, RP2 mon...
Replimune Group, Inc. recently announced that, following collaborative discussions, it has aligned with the U.S. FDA on a prioritized resubmission and review pa...
Replimune (REPL) Group presented 3-year landmark overall survival data from the IGNYTE clinical trial of RP1 plus nivolumab in patients with anti-PD-1 failed me...
Analyst ratings
63%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.